|
MedChemExpress
mce hy Mce Hy, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/FIPI/us12501868-273-191-191 Average 94 stars, based on 1 article reviews
mce hy - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
TargetMol
fipi ![]() Fipi, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/FIPI/10__1158_slash_0008___5472__can___22___0717-94-0-8 Average 97 stars, based on 1 article reviews
fipi - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
Tocris
phospholipase a 2 inhibitor fipi ![]() Phospholipase A 2 Inhibitor Fipi, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/FIPI/pmc04055770-192-66-79 Average 93 stars, based on 1 article reviews
phospholipase a 2 inhibitor fipi - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Tocris
fipi ![]() Fipi, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/FIPI/pmc08036943-129-6-18 Average 93 stars, based on 1 article reviews
fipi - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
pld inhibitor fipi ![]() Pld Inhibitor Fipi, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/FIPI/pmc05561184-160-10-22 Average 90 stars, based on 1 article reviews
pld inhibitor fipi - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
fipi ![]() Fipi, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/FIPI/pm38056454-313-28-30 Average 93 stars, based on 1 article reviews
fipi - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
inhibitor 5 fluoro 2 indolyl des chlorohalopemide fipi ![]() Inhibitor 5 Fluoro 2 Indolyl Des Chlorohalopemide Fipi, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/FIPI+hydrochloride/pmc05436581-41-23-28 Average 86 stars, based on 1 article reviews
inhibitor 5 fluoro 2 indolyl des chlorohalopemide fipi - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Novartis
small molecule pld inhibitors ![]() Small Molecule Pld Inhibitors, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/pld+inhibitor+pldi+fipi/pmc04132764-37-20-17 Average 90 stars, based on 1 article reviews
small molecule pld inhibitors - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Novartis
fipi ![]() Fipi, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/fipi/10__1074_slash_jbc__r114__576876-39-26-15 Average 90 stars, based on 1 article reviews
fipi - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Olon Ricerca Bioscience
fipi ![]() Fipi, supplied by Olon Ricerca Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/fipi/pmc04355084-54-23-26 Average 90 stars, based on 1 article reviews
fipi - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Lantronix Inc
xpico wi-fi pi plate ![]() Xpico Wi Fi Pi Plate, supplied by Lantronix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/xpico+wi+fi+pi+plate/10__1177_slash_0020294014559162-143-2-5 Average 90 stars, based on 1 article reviews
xpico wi-fi pi plate - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Janvier Labs
the pld inhibitor fipi ![]() The Pld Inhibitor Fipi, supplied by Janvier Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/fipi/the+pld+inhibitor+fipi/pmc06281985-43-24-20 Average 90 stars, based on 1 article reviews
the pld inhibitor fipi - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cancer Research
Article Title: DLGAP1-AS2–Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma
doi: 10.1158/0008-5472.can-22-0717
Figure Lengend Snippet: Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
Article Snippet:
Techniques: Activation Assay, Western Blot, Phospho-proteomics, Expressing, Quantitative RT-PCR, Two Tailed Test, Control
Journal: Molecules
Article Title: ACTH(6–9)PGP Peptide Protects SH-SY5Y Cells from H 2 O 2 , tert -Butyl Hydroperoxide, and Cyanide Cytotoxicity via Stimulation of Proliferation and Induction of Prosurvival-Related Genes
doi: 10.3390/molecules26071878
Figure Lengend Snippet: Participation of intracellular signal transduction components in ACTH(6–9)PGP protection against KCN cytotoxicity for the SH-SY5Y cells. Inhibitors for CREB (666-11, 1 µM), JNK (SP 600125, “SP”, 1 µM), p38 (SB 202190, “SB”, 1 µM), CaMKII + IV (KN-93, 4 µM), PKC + PKA (HA-1004, 10 µM), PLD (FIPI, 0.5 µM), PKA (KT-5720, 0.5 µM), PLC (U-73122, “U73”, 10 µM), MEK1/2 (U-0126, 0.2 µM), NOS (L-NAME, 25 µM), and Ras (salirasib, 10 µM) were added 1 h before the KCN and then together with KCN (85.0 µM) and peptide (50 µM). The cells were incubated with the inhibitors, KCN, and peptide for 24 h. MTT assay data, mean ± standard error. *, a statistically significant difference from the KCN + peptide without any inhibitor; **, a statistically significant difference from the untreated control; p ≤ 0.05, ANOVA with the Tukey post-test, N = 3 experiments.
Article Snippet: 666-11, SB 202190, SP 600125, salirasib,
Techniques: Transduction, Incubation, MTT Assay, Control
Journal: Frontiers in Physiology
Article Title: Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF-α Regulation and Myocardial Healing
doi: 10.3389/fphys.2018.01698
Figure Lengend Snippet: FIPI has no influence on infarct size or left ventricular function 24 h post MI in mouse hearts. (A) Quantitative analysis of infarct size as the percentage of area at risk (% Inf/AaR), of the area at risk as percentage of the left ventricle and of the infarct size as percentage of the left ventricle showed no differences in comparison of the control and FIPI-treated group in TTC-stained left ventricles 24 h after I/R (control n = 12, FIPI n = 13). (B) Representative pictures. Blue = healthy tissue, red = the area at risk (AAR), white = infarcted area (INF). (C) Echocardiographic analysis of ejection fraction (baseline vs. 24 h after I/R), cardiac output (baseline vs. 24 h after I/R) and fractional shortening (baseline vs. 24 h after I/R) of C57BL6/J mice treated with FIPI (3 mg/kg bodyweight in 4% DMSO/PBS) vs. controls showed no differences (control n = 20, FIPI n = 23).
Article Snippet: For the analysis of the impact of PLD enzymatic activity on myocardial ischemia and reperfusion injury, treatment of C57BL/6J mice (
Techniques: Comparison, Control, Staining
Journal: Frontiers in Physiology
Article Title: Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF-α Regulation and Myocardial Healing
doi: 10.3389/fphys.2018.01698
Figure Lengend Snippet: Pharmacological inhibition of PLD enzymatic activity reduces the inflammatory response 24 h post MI in mice. Twenty four hours post MI, cardiac sections of FIPI-treated mice (3 mg/kg bodyweight in 4% DMSO/PBS) vs. controls were stained with either hematoxylin/eosin (A) or immune cell specific antibodies for neutrophils (B) and macrophages (C) to analyze the migration of inflammatory cells into the infarct border zone (n = 5). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. (D,E) Flow cytometric analysis of platelet-immune cell-aggregate formation 0, 24, and 72 h post MI in FIPI-treated mice vs. controls; Platelet – leukocyte-aggregate formation left, platelet – neutrophile – aggregate formation right ( n = 5–21). (F) Quantitative analysis of IL-1β in plasma of FIPI-treated mice vs. control 24 h post MI (control n = 14; FIPI n = 16). (G) Analysis of IL-1β expression in the left ventricle of Pld1 +/+ /Pld2 +/+ vs. Pld1 -/- /Pld2 -/- mice 24 h post MI using quantitative RT-PCR ( Pld1 +/+ /Pld2 +/+ n = 3, Pld1 -/- /Pld2 -/- n = 4). (H) Quantitative analysis of IL-6 expression in the left ventricle of FIPI-treated vs. control mice 24 h post MI (control n = 5; FIPI n = 6). Scale bar: 50 μm, magnification: 400×.
Article Snippet: For the analysis of the impact of PLD enzymatic activity on myocardial ischemia and reperfusion injury, treatment of C57BL/6J mice (
Techniques: Inhibition, Activity Assay, Staining, Migration, Clinical Proteomics, Control, Expressing, Quantitative RT-PCR
Journal: Frontiers in Physiology
Article Title: Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF-α Regulation and Myocardial Healing
doi: 10.3389/fphys.2018.01698
Figure Lengend Snippet: Treatment with FIPI shows no alterations in cell apoptosis after I/R. (A) Analysis of quantitative RT-PCR shows no differences in the expression of the cell apoptosis markers Bax, Bcl-xl , and Bcl -2 in the left ventricle (LV) of FIPI-treated mice (3 mg/kg bodyweight in 4% DMSO/PBS) vs. control mice 24 h post MI (control n = 5, FIPI n = 6). (B) Number of caspase-3 positive cells in the infarct border zone is not different between FIPI-treated vs. control mice 21 days post MI (control n = 4, FIPI n = 5) (C) After I/R in vitro the amount of activated caspase3 in HL-1 cells is not altered after FIPI-treatment ( n = 4). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.
Article Snippet: For the analysis of the impact of PLD enzymatic activity on myocardial ischemia and reperfusion injury, treatment of C57BL/6J mice (
Techniques: Quantitative RT-PCR, Expressing, Control, In Vitro
Journal: Frontiers in Physiology
Article Title: Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF-α Regulation and Myocardial Healing
doi: 10.3389/fphys.2018.01698
Figure Lengend Snippet: FIPI treatment has no influence on scar formation 21 d post MI. (A) No alterations in infarct size ( n = 6) and (B) left ventricular function 21 days post MI in FIPI (3 mg/kg bodyweight in 4% DMSO/PBS) treated mice vs. controls ( n = 14–18). (C) Sirius red staining of remote myocardium shows no differences in the amount of interstitial collagen between FIPI-treated mice vs. controls (control n = 9, FIPI n = 6) (D) Quantification of α-SMA positive myofibroblasts in the border zone of infarcted hearts 21 days post MI in FIPI-treated mice vs. control mice shows no alterations between the groups. Representative pictures are shown (control n = 9, FIPI n = 6). Scale bar: 50 μm, magnification: 400×.
Article Snippet: For the analysis of the impact of PLD enzymatic activity on myocardial ischemia and reperfusion injury, treatment of C57BL/6J mice (
Techniques: Staining, Control
Journal: Frontiers in Physiology
Article Title: Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF-α Regulation and Myocardial Healing
doi: 10.3389/fphys.2018.01698
Figure Lengend Snippet: Hemodynamic measurements after MI.
Article Snippet: For the analysis of the impact of PLD enzymatic activity on myocardial ischemia and reperfusion injury, treatment of C57BL/6J mice (
Techniques: Control
Journal: Frontiers in Physiology
Article Title: Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF-α Regulation and Myocardial Healing
doi: 10.3389/fphys.2018.01698
Figure Lengend Snippet: TNF-α signaling is independent of the enzymatic activity of PLD. (A) TNF-α expression in the left ventricle of infarcted hearts shows no alterations in FIPI-treated (3 mg/kg bodyweight in 4% DMSO/PBS) vs. control mice 24 h post MI (control n = 5, FIPI n = 6). (B) TNF-α expression in the left ventricle of Pld1 +/+ /Pld2 +/+ vs. Pld1 -/- /Pld2 -/- mice 24 h post MI was significantly decreased in mutant mice ( Pld1 +/+ /Pld2 +/+ n = 3/4; Pld1 -/- /Pld2 -/- n = 3/5). (C) Pld1 +/+ -MEFs were treated with FIPI (1 μM in DMSO/PBS, 30 min prior LPS treatment), stimulated with LPS (1 μg/ml) for different time periods as indicated and the TNF-α release was measured via ELISA. No differences in TNF-α release were observed in FIPI-treated MEFs compared to untreated controls ( n = 5). (D) Pld1 -/- - MEFs were treated with FIPI (1 μM in DMSO/PBS) and stimulated with LPS (1 μg/ml) for 12 h. TNF-α release was measured by ELISA. TNF-α release of Pld1 -/- -MEFs and Pld1 -/- -MEFs treated with FIPI was decreased in comparison to Pld1 +/+ - MEFs ( n = 5). LV = left ventricle. ∗∗ P < 0.01 and ∗∗∗ P < 0.001.
Article Snippet: For the analysis of the impact of PLD enzymatic activity on myocardial ischemia and reperfusion injury, treatment of C57BL/6J mice (
Techniques: Activity Assay, Expressing, Control, Mutagenesis, Enzyme-linked Immunosorbent Assay, Comparison